Dialyzers Market is estimated to be US$ 17.57 billion by 2030 with a CAGR of 5.52% during the forecast period

Over the analysis period, the increasing prevalence of kidney illnesses will increase demand for dialyzers. Chronic kidney disease is primarily caused by high blood pressure and diabetes. As a result, growing diabetes, hypertension, and other related illnesses will boost demand for dialyzers in the coming years. According to the Centers for Disease Control and Prevention (CDC), around 37 million persons in the United States were predicted to have chronic renal disease in 2019. As a result, the rising prevalence of chronic renal illness will promote total industry growth. During the analysis period, the growing geriatric population base will drive the dialyzers market expansion. End-stage renal disease is more common in people over the age of 65. (ESRD). Geriatric population has been steadily increasing in recent years, and this trend is expected to continue over the projection period. Dialyzer use will increase due to an increase in the senior population.

Region Analysis:

North America dominates the global market due to the region's increased incidence of renal disorders, improved diagnostics, rising per capita health care spending, and high disposable income. ESRD affects around 96,000 persons in the United States. Due to the growing elderly population, increasing frequency of renal disorders, and rising adoption of innovative products to treat chronic kidney conditions, Europe is predicted to be the second-largest market. Because of the existence of expanding economies, rising health-care expenditures, and a constantly growing population, Asia Pacific is seen as an emerging market for dialyzers.

Key Highlight:

• Mar Cor (Cantel Medical Corporation) announced the release of its unique EON Portable Hemodialysis Water System in 2021.
• Fresenius Medical Care AG & Co. KGaA announced the release of a PVC-free peritoneal dialysis solution bag for home dialysis therapy in 2020.
• Baxter International Inc. gained FDA approval for a De Novo application for Theranova dilayzers designed to provide enhanced hemodialysis (HDx) therapy in 2020.

Before purchasing this report, request a sample or make an inquiry by clicking the following link: 

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4881

Key Market Insights from the report:

Global Dialyzers Market accounted for US$ 10.31 billion in 2020 and is estimated to be US$ 17.57 billion by 2030 and is anticipated to register a CAGR of 5.52%.  The Global Dialyzers Market report segments the market on the basis of type, end-user and region.

• Based on Type, Global Dialyzers Market is segmented into High-Flux Dialyzer and Low-Flux Dialyzer.   
• Based on End-User, Global Dialyzers Market is segmented into In-Center and Home Dialysis.
• By Region, the Global Dialyzers Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Dialyzers Market:

The key players operating in the Global Dialyzers Market includes Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Browndove Healthcare (P) Ltd, Bain Medical Equipment, Fresenius Medical Care AG & Co. KGaA, Kawasumi Laboratories Inc., NIKKISO CO., LTD., Medtronic Plc. (Bellco), Jihua Medical Apparatus & Instruments Co., Ltd, Allmed Medical Care Holdings Limited, Weigao group, Farmasol, China Chengdu Wesley Biotech Co., Ltd, Toray Industries, Inc., Medica Group, JMS Co. Ltd, Jiangsu Lengthen Life Science and Technology Co., Ltd, Medivators, Inc. and Dialifegroup.